Previous Article | Next Article 
Journal of Virology, June 2004, p. 6005-6012, Vol. 78, No. 11
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.11.6005-6012.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Species-Specific Tropism Determinants in the Human Immunodeficiency Virus Type 1 Capsid
Theodora Hatziioannou,1 Simone Cowan,1 Uta K. von Schwedler,2 Wesley I. Sundquist,2 and Paul D. Bieniasz1*
Aaron Diamond AIDS Research Center and the Rockefeller University, New York, New York 10016,1
Department of Biochemistry, University of Utah, Salt Lake City, Utah 841322
Received 14 November 2003/
Accepted 24 January 2004
Retroviral tropism is determined in part by cellular restriction factors that block infection by targeting the incoming viral capsid. Indeed, human immunodeficiency virus type 1 (HIV-1) infection of many nonhuman primate cells is inhibited by one such factor, termed Lv1. In contrast, a restriction factor in humans, termed Ref1, does not inhibit HIV-1 infection unless nonnatural mutations are introduced into the HIV-1 capsid protein (CA). Here, we examined the infectivity of a panel of mutant HIV-1 strains carrying substitutions in the N-terminal CA domain in cells that exhibit restriction attributable to Lv1 or Ref1. Manipulation of HIV-1 CA could alter HIV-1 tropism, and several mutations were identified that increased or decreased HIV-1 infectivity in a target-cell-specific manner. Many residues that affected HIV-1 tropism were located in the three variable loops that lie on the outer surface of the modeled HIV-1 conical capsid. Some tropism determinants, including the CypA binding site, coincided with residues whose mutation conferred on HIV-1 CA the ability to saturate Ref1 in human cells. Notably, a mutation that reverses the infectivity defect in human cells induced by CypA binding site mutation inhibits recognition by Ref1. Overall, these findings demonstrate that exposed variable loops in CA and a partial CypA "coat" can modulate restriction and HIV-1 tropism and suggest a model in which the exposed surface of the incoming retroviral capsid is the target for inhibition by host cell-specific restriction factors.
* Corresponding author. Mailing address: AIDS Research Center, 455 First Ave., New York, NY 10021. Phone: (212) 448-5070. Fax: (212) 725-1126. E-mail: pbienias{at}adarc.org.
Journal of Virology, June 2004, p. 6005-6012, Vol. 78, No. 11
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.11.6005-6012.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kratovac, Z., Virgen, C. A., Bibollet-Ruche, F., Hahn, B. H., Bieniasz, P. D., Hatziioannou, T.
(2008). Primate Lentivirus Capsid Sensitivity to TRIM5 Proteins. J. Virol.
82: 6772-6777
[Abstract]
[Full Text]
-
Ptak, R. G., Gallay, P. A., Jochmans, D., Halestrap, A. P., Ruegg, U. T., Pallansch, L. A., Bobardt, M. D., de Bethune, M.-P., Neyts, J., De Clercq, E., Dumont, J.-M., Scalfaro, P., Besseghir, K., Wenger, R. M., Rosenwirth, B.
(2008). Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent. Antimicrob. Agents Chemother.
52: 1302-1317
[Abstract]
[Full Text]
-
Song, H., Nakayama, E. E., Yokoyama, M., Sato, H., Levy, J. A., Shioda, T.
(2007). A Single Amino Acid of the Human Immunodeficiency Virus Type 2 Capsid Affects Its Replication in the Presence of Cynomolgus Monkey and Human TRIM5{alpha}s. J. Virol.
81: 7280-7285
[Abstract]
[Full Text]
-
Luban, J.
(2007). Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection. J. Virol.
81: 1054-1061
[Full Text]
-
Spidel, J. L., Wilson, C. B., Craven, R. C., Wills, J. W.
(2007). Genetic Studies of the {beta}-Hairpin Loop of Rous Sarcoma Virus Capsid Protein. J. Virol.
81: 1288-1296
[Abstract]
[Full Text]
-
Chatterji, U., Bobardt, M. D., Gaskill, P., Sheeter, D., Fox, H., Gallay, P. A.
(2006). Trim5{alpha} Accelerates Degradation of Cytosolic Capsid Associated with Productive HIV-1 Entry. J. Biol. Chem.
281: 37025-37033
[Abstract]
[Full Text]
-
Ylinen, L. M. J., Keckesova, Z., Webb, B. L. J., Gifford, R. J. M., Smith, T. P. L., Towers, G. J.
(2006). Isolation of an Active Lv1 Gene from Cattle Indicates that Tripartite Motif Protein-Mediated Innate Immunity to Retroviral Infection Is Widespread among Mammals.. J. Virol.
80: 7332-7338
[Abstract]
[Full Text]
-
Li, Y., Li, X., Stremlau, M., Lee, M., Sodroski, J.
(2006). Removal of Arginine 332 Allows Human TRIM5{alpha} To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection. J. Virol.
80: 6738-6744
[Abstract]
[Full Text]
-
Li, X., Li, Y., Stremlau, M., Yuan, W., Song, B., Perron, M., Sodroski, J.
(2006). Functional Replacement of the RING, B-Box 2, and Coiled-Coil Domains of Tripartite Motif 5{alpha} (TRIM5{alpha}) by Heterologous TRIM Domains.. J. Virol.
80: 6198-6206
[Abstract]
[Full Text]
-
Si, Z., Vandegraaff, N., O'hUigin, C., Song, B., Yuan, W., Xu, C., Perron, M., Li, X., Marasco, W. A., Engelman, A., Dean, M., Sodroski, J.
(2006). Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. USA
103: 7454-7459
[Abstract]
[Full Text]
-
Keckesova, Z., Ylinen, L. M. J., Towers, G. J.
(2006). Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5{alpha} Antiviral Activity.. J. Virol.
80: 4683-4690
[Abstract]
[Full Text]
-
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., Sodroski, J.
(2006). From the Cover: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5{alpha} restriction factor. Proc. Natl. Acad. Sci. USA
103: 5514-5519
[Abstract]
[Full Text]
-
Speelmon, E. C., Livingston-Rosanoff, D., Li, S. S., Vu, Q., Bui, J., Geraghty, D. E., Zhao, L. P., McElrath, M. J.
(2006). Genetic Association of the Antiviral Restriction Factor TRIM5{alpha} with Human Immunodeficiency Virus Type 1 Infection. J. Virol.
80: 2463-2471
[Abstract]
[Full Text]
-
Yueh, A., Leung, J., Bhattacharyya, S., Perrone, L. A., de los Santos, K., Pu, S.-y., Goff, S. P.
(2006). Interaction of Moloney Murine Leukemia Virus Capsid with Ubc9 and PIASy Mediates SUMO-1 Addition Required Early in Infection. J. Virol.
80: 342-352
[Abstract]
[Full Text]
-
Gudmundsson, B., Jonsson, S. R., Olafsson, O., Agnarsdottir, G., Matthiasdottir, S., Georgsson, G., Torsteinsdottir, S., Svansson, V., Kristbjornsdottir, H. B., Franzdottir, S. R., Andresson, O. S., Andresdottir, V.
(2005). Simultaneous Mutations in CA and Vif of Maedi-Visna Virus Cause Attenuated Replication in Macrophages and Reduced Infectivity In Vivo. J. Virol.
79: 15038-15042
[Abstract]
[Full Text]
-
Saenz, D. T., Teo, W., Olsen, J. C., Poeschla, E. M.
(2005). Restriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5{alpha} Proteins. J. Virol.
79: 15175-15188
[Abstract]
[Full Text]
-
Hatziioannou, T., Martin-Serrano, J., Zang, T., Bieniasz, P. D.
(2005). Matrix-Induced Inhibition of Membrane Binding Contributes to Human Immunodeficiency Virus Type 1 Particle Assembly Defects in Murine Cells. J. Virol.
79: 15586-15589
[Abstract]
[Full Text]
-
Mische, C. C., Javanbakht, H., Song, B., Diaz-Griffero, F., Stremlau, M., Strack, B., Si, Z., Sodroski, J.
(2005). Retroviral Restriction Factor TRIM5{alpha} Is a Trimer. J. Virol.
79: 14446-14450
[Abstract]
[Full Text]
-
Berthoux, L., Sebastian, S., Sokolskaja, E., Luban, J.
(2005). Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc. Natl. Acad. Sci. USA
102: 14849-14853
[Abstract]
[Full Text]
-
Ylinen, L. M. J., Keckesova, Z., Wilson, S. J., Ranasinghe, S., Towers, G. J.
(2005). Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5{alpha} Alleles. J. Virol.
79: 11580-11587
[Abstract]
[Full Text]
-
Marchant, D., Neil, S. J. D., Aubin, K., Schmitz, C., McKnight, A.
(2005). An Envelope-Determined, pH-Independent Endocytic Route of Viral Entry Determines the Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 to Lv2 Restriction. J. Virol.
79: 9410-9418
[Abstract]
[Full Text]
-
Javanbakht, H., Diaz-Griffero, F., Stremlau, M., Si, Z., Sodroski, J.
(2005). The Contribution of RING and B-box 2 Domains to Retroviral Restriction Mediated by Monkey TRIM5{alpha}. J. Biol. Chem.
280: 26933-26940
[Abstract]
[Full Text]
-
Nakayama, E. E., Miyoshi, H., Nagai, Y., Shioda, T.
(2005). A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5{alpha} Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection. J. Virol.
79: 8870-8877
[Abstract]
[Full Text]
-
Song, B., Gold, B., O'hUigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M., Sodroski, J.
(2005). The B30.2(SPRY) Domain of the Retroviral Restriction Factor TRIM5{alpha} Exhibits Lineage-Specific Length and Sequence Variation in Primates. J. Virol.
79: 6111-6121
[Abstract]
[Full Text]
-
Lassaux, A., Sitbon, M., Battini, J.-L.
(2005). Residues in the Murine Leukemia Virus Capsid That Differentially Govern Resistance to Mouse Fv1 and Human Ref1 Restrictions. J. Virol.
79: 6560-6564
[Abstract]
[Full Text]
-
Song, B., Javanbakht, H., Perron, M., Park, D. H., Stremlau, M., Sodroski, J.
(2005). Retrovirus Restriction by TRIM5{alpha} Variants from Old World and New World Primates. J. Virol.
79: 3930-3937
[Abstract]
[Full Text]
-
Stremlau, M., Perron, M., Welikala, S., Sodroski, J.
(2005). Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5{alpha} Determines the Potency of Human Immunodeficiency Virus Restriction. J. Virol.
79: 3139-3145
[Abstract]
[Full Text]
-
Forshey, B. M., Shi, J., Aiken, C.
(2005). Structural Requirements for Recognition of the Human Immunodeficiency Virus Type 1 Core during Host Restriction in Owl Monkey Cells. J. Virol.
79: 869-875
[Abstract]
[Full Text]
-
Hatziioannou, T., Perez-Caballero, D., Cowan, S., Bieniasz, P. D.
(2005). Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells. J. Virol.
79: 176-183
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.